Oncolytic virotherapy, Nature Biotechnology, vol.311, issue.7, pp.658-70, 2012. ,
DOI : 10.1126/science.1121411
Going viral with cancer immunotherapy, Nature Reviews Cancer, vol.15, issue.8, pp.559-67, 2014. ,
DOI : 10.1038/sj.cgt.7701105
Oncolytic viruses as therapeutic cancer vaccines, Molecular Cancer, vol.12, issue.1, p.103, 2013. ,
DOI : 10.1186/1476-4598-12-103
URL : https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-12-103?site=molecular-cancer.biomedcentral.com
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies, Molecular Therapy, vol.22, issue.2, pp.251-257, 2014. ,
DOI : 10.1038/mt.2013.220
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy, Nature Reviews Cancer, vol.95, issue.2, pp.135-181, 2014. ,
DOI : 10.1084/jem.193.10.1189
Immune targets and neoantigens for cancer immunotherapy and precision medicine, Cell Research, vol.15, issue.1, pp.11-37, 2017. ,
DOI : 10.1038/nrd.2016.201
Simultaneous Humoral and Cellular Immune Response against Cancer???Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2???binding Peptide Epitopes, The Journal of Experimental Medicine, vol.157, issue.2, pp.265-70, 1998. ,
DOI : 10.1097/00008390-199612000-00003
NY-ESO-1???specific TCR???engineered T cells mediate sustained antigen-specific antitumor effects in myeloma, Nature Medicine, vol.72, issue.8, pp.914-935, 2015. ,
DOI : 10.1182/blood-2009-04-217604
The Tumor Antigen NY ,
URL : https://hal.archives-ouvertes.fr/inserm-01285160
Autophagy proteins in antigen processing for presentation on MHC molecules, Immunological Reviews, vol.206, issue.M111, pp.17-27, 2016. ,
DOI : 10.1084/jem.20082108
Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer cell, Gene Ther, vol.154, issue.144, pp.1361-71263, 2003. ,
An Oncolytic HSV-1 Mutant Expressing ICP34.5 under Control of a Nestin Promoter Increases Survival of Animals even when Symptomatic from a Brain Tumor, Cancer Research, vol.65, issue.7, pp.2832-2841, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-3227
Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. European patent EP2826856. 18. Coffin RS. From virotherapy to oncolytic immunotherapy: where are we now? Oncolytic immunotherapy: the new clinical outbreak, Curr Opin Virol. Oncoimmunology, vol.135, issue.191, pp.93-100, 2015. ,
Induction of immunogenic tumor cell death by attenuated oncolytic measles virus Measles virus causes immunogenic cell death in human melanoma, J Clin Cell Immunol, vol.6, issue.21, p.291, 2013. ,
Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells, Clinical Cancer Research, vol.19, issue.5, pp.1147-58, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2733
URL : http://clincancerres.aacrjournals.org/content/clincanres/19/5/1147.full.pdf
Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, Cancer Research, vol.75, issue.1, pp.22-30, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-2533
URL : http://cancerres.aacrjournals.org/content/canres/75/1/22.full.pdf
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer, Nature Medicine, vol.53, issue.3, pp.329-365, 2013. ,
DOI : 10.1080/01621459.1958.10501452
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial, Annals of Surgical Oncology, vol.45, issue.2, pp.4169-77, 2016. ,
DOI : 10.1016/j.ejca.2008.10.026
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Clin Cancer Res Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ Tcell clones using peptide pulsed mature dendritic cells, J Clin Oncol. Journal of immunological methods, vol.1034258, issue.2912, pp.8396-4042619, 2001. ,
The tight interallelic positional coincidence that distinguishes T-cell receptor Jalpha usage does not result from homologous chromosomal pairing during ValphaJalpha rearrangement, The EMBO Journal, vol.20, issue.17, pp.4717-4746, 2001. ,
DOI : 10.1093/emboj/20.17.4717
Human T-cell receptor variable gene segment families, Immunogenetics, vol.42, issue.6, pp.455-500, 1995. ,
DOI : 10.1007/BF00172176
A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice, Journal of Virology, vol.77, issue.21, pp.11546-54, 2003. ,
DOI : 10.1128/JVI.77.21.11546-11554.2003
Fiji: an open-source platform for biological-image analysis, Nature Methods, vol.27, issue.7, pp.676-82, 2012. ,
DOI : 10.1093/bioinformatics/btr390
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855844/pdf
or PI+ cells was measured by flow cytometry. Indicated values are means ± SEM of three independent experiments ,